Evidence map›Paper›PMID 28598606›Full record

ArticleJournal of the American Chemical Society2017

4S-Hydroxylation of Insulin at ProB28 Accelerates Hexamer Dissociation and Delays Fibrillation.

Seth A Lieblich, Katharine Y Fang, Jackson K B Cahn, Jeffrey Rawson, Jeanne LeBon, H Teresa Ku, David A Tirrell

Open access · greenAbstract read
In one paragraph

Article in Journal of the American Chemical Society, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. How To Quantify a Genetic Firewall? A Polarity-Based Metric for Genetic Code Engineering.Chembiochem : a European journal of chemical biology · 2021
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Seth A LieblichDivision of Chemistry and Chemical Engineering, California Institute of Technology , Pasadena, California 91125, United States.ORCID 0000-0003-2705-5821
Katharine Y FangDivision of Chemistry and Chemical Engineering, California Institute of Technology , Pasadena, California 91125, United States.
Jackson K B CahnDivision of Chemistry and Chemical Engineering, California Institute of Technology , Pasadena, California 91125, United States.
Jeffrey RawsonDepartment of Translational Research and Cellular Therapeutics, Diabetes and Metabolism Research Institute, City of Hope , Duarte, California 91010, United States.
Jeanne LeBonDepartment of Translational Research and Cellular Therapeutics, Diabetes and Metabolism Research Institute, City of Hope , Duarte, California 91010, United States.
H Teresa KuDepartment of Translational Research and Cellular Therapeutics, Diabetes and Metabolism Research Institute, City of Hope , Duarte, California 91010, United States.
David A TirrellDivision of Chemistry and Chemical Engineering, California Institute of Technology , Pasadena, California 91125, United States.
California Institute of Technology · USCity of Hope · US

Funding

EX VIVO DIFFERENTIATION AND EXPANSION OF ADULT PANCREATIC COLONY-FORMING UNITSR01DK099734 · NIDDK · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI KU, HSUN TERESA · 2014 to 2018
$1.9M
Fractionation, Purification and Characterization of Adult Pancreatic Colony-Forming Progenitor CellsR56DK099734 · NIDDK · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI KU, HSUN TERESA · 2019 to 2019
$132k
NIDDK NIH HHS R01 DK099734NIDDK NIH HHS R56 DK099734
6 · The paper itself

Abstract

Daily injections of insulin provide lifesaving benefits to millions of diabetics. But currently available prandial insulins are suboptimal: The onset of action is delayed by slow dissociation of the insulin hexamer in the subcutaneous space, and insulin forms amyloid fibrils upon storage in solution. Here we show, through the use of noncanonical amino acid mutagenesis, that replacement of the proline residue at position 28 of the insulin B-chain (ProB28) by (4S)-hydroxyproline (Hzp) yields an active form of insulin that dissociates more rapidly, and fibrillates more slowly, than the wild-type protein. Crystal structures of dimeric and hexameric insulin preparations suggest that a hydrogen bond between the hydroxyl group of Hzp and a backbone amide carbonyl positioned across the dimer interface may be responsible for the altered behavior. The effects of hydroxylation are stereospecific; replacement of ProB28 by (4R)-hydroxyproline (Hyp) causes little change in the rates of fibrillation and hexamer disassociation. These results demonstrate a new approach that fuses the concepts of medicinal chemistry and protein design, and paves the way to further engineering of insulin and other therapeutic proteins.

Indexed as

AmyloidCrystallography, X-RayDimerizationHydroxylationHydroxyprolineInsulinModels, BiologicalModels, MolecularProinsulinAmyloidHydroxyprolineInsulinProinsulin

Identifiers

PMID28598606
PMCPMC5812673
OpenAlexW2624136383

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.